We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

45 hedge funds and large institutions have $19.4M invested in Abeona Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 10

0% more funds holding

Funds holding: 45 → 45 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

25% less capital invested

Capital invested by funds: $26M → $19.4M (-$6.62M)

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
13
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$203K
2
SM
Sabby Management
Florida
+$90.3K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$71.7K
4
BFA
BlackRock Fund Advisors
California
+$62.8K
5
SG Americas Securities
SG Americas Securities
New York
+$43K

Top Sellers

Rank Fund Capital Flow
1
GP
GLG Partners
United Kingdom
-$434K
2
SFM
Sphera Funds Management
Israel
-$350K
3
NI
Numeric Investors
Massachusetts
-$72K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$44K
5
IA
IFP Advisors
Florida
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$31K – – –
Morgan Stanley
27
Morgan Stanley
New York
$29K -$662 -10 -2%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$24K – – –
Citigroup
29
Citigroup
New York
$24K +$15.6K +236 +170%
NFA
30
Nationwide Fund Advisors
Ohio
$17K – – –
AIG
31
American International Group
New York
$15K – – –
AIM
32
Acrospire Investment Management
Illinois
$9K +$9.27K +140 New
TRCT
33
Tower Research Capital (TRC)
New York
$8K -$6.75K -102 -46%
BA
34
BlackRock Advisors
Delaware
$7K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7K +$6.69K +101 +2,020%
Creative Planning
36
Creative Planning
Kansas
$6K – – –
Bank of America
37
Bank of America
North Carolina
$5K -$397 -6 -7%
Deutsche Bank
38
Deutsche Bank
Germany
$4K -$2.98K -45 -40%
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$3.75K -$1.66K -25 -30%
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$3K – – –
Wells Fargo
41
Wells Fargo
California
$3K +$2.32K +35 +269%
CG
42
Cutler Group
California
$1K – – –
BlackRock
43
BlackRock
New York
$1K +$927 +14 New
Geode Capital Management
44
Geode Capital Management
Massachusetts
$180 +$26.7K +403 +17%
GP
45
GLG Partners
United Kingdom
– -$434K -5,165 Closed
NI
46
Numeric Investors
Massachusetts
– -$72K -858 Closed
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
– -$44K -520 Closed
UBS Group
48
UBS Group
Switzerland
– -$1.52K -23 Closed
Simplex Trading
49
Simplex Trading
Illinois
– +$530 +8 New
1
2

ABEO Hedge Fund Activity: Q1 2016 in Review

45 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2016, worth a combined $19.4M — down 25% from $26M a quarter earlier.

Fund positioning in ABEO was balanced in Q1 2016: 4 funds opened new positions, 4 closed out, 13 added to existing stakes and 10 trimmed.

The largest buyer was Royce & Associates, adding an estimated $203K. The largest seller was GLG Partners, exiting entirely with an estimated $434K sold.

  • 45 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $19.4M of Abeona Therapeutics stock for Q1 2016, down 25% quarter-over-quarter.
  • 4 funds opened new Abeona Therapeutics positions in Q1 2016 and 4 closed out, a net change of 0 holders.
  • The largest Abeona Therapeutics buyer in Q1 2016 was Royce & Associates, an estimated $203K added.
  • The largest Abeona Therapeutics seller in Q1 2016 was GLG Partners, an estimated $434K sold.

Based on aggregated 13F filings for Q1 2016.